India has unveiled its first indigenous vaccine against the H5N1 bird flu virus, marking an important development in the country’s efforts to protect its poultry industry from recurring avian influenza outbreaks. Developed by scientists at the Indian Council of Agricultural Research-National Institute of High Security Animal Diseases (ICAR-NIHSAD) in Bhopal, the inactivated vaccine specifically targets the H5N1 Clade 2.3.2.1a strain circulating in India.

Union Agriculture and Farmers Welfare Minister Shivraj Singh Chouhan dedicated the vaccine to the nation on November 20, 2026, at ICAR-NIHSAD in Bhopal. The development comes as bird flu continues to threaten poultry farmers through large-scale bird deaths, compulsory culling and movement restrictions. The government expects the indigenous vaccine to strengthen disease prevention and reduce the economic damage associated with future outbreaks.

India Develops Its First Indigenous H5N1 Vaccine

The new vaccine has been developed entirely through domestic research at ICAR-NIHSAD, an institute operating under the Indian Council of Agricultural Research (ICAR).

It is an inactivated vaccine designed to protect chickens against Highly Pathogenic Avian Influenza (HPAI) caused by the H5N1 virus.

More specifically, the vaccine targets Clade 2.3.2.1a, a genetic variant that has been responsible for most H5N1 outbreaks in Indian poultry populations.

The development addresses an important gap in India’s animal healthcare infrastructure. According to the Ministry of Agriculture and Farmers Welfare, no specific commercial vaccine was previously available against the circulating H5N1 Clade 2.3.2.1a strain.

Developing a vaccine against the locally circulating strain could help India strengthen its ability to manage bird flu outbreaks without depending entirely on external vaccine technologies.

How the New Bird Flu Vaccine Works

The vaccine uses an inactivated version of the virus to stimulate an immune response in chickens without causing the disease itself.

Once vaccinated, chickens can develop immunity against the targeted H5N1 strain, helping protect poultry populations against severe infections.

According to research findings reported by The Times of India, experimental trials demonstrated protection lasting up to six months.

The institute also reported that vaccinated chickens prevented transmission to other chickens kept in contact with them during experimental testing.

The vaccine reportedly passed safety and efficacy assessments involving specific-pathogen-free layer and grower chickens.

The institute has made the technology available for commercial production, with potential applications particularly among layer and breeder poultry populations.

However, commercial manufacturing arrangements, vaccine pricing, production capacity and the nationwide rollout schedule have not yet been officially established.

Why India Needs an H5N1 Vaccine

Bird flu is one of the most serious infectious diseases affecting poultry populations.

Highly Pathogenic Avian Influenza can spread rapidly among susceptible birds and cause extremely high mortality rates. In severe outbreaks, infected flocks may experience mortality approaching 100%.

India first detected bird flu in 2006. Since then, more than 500 combined outbreaks involving H5N1 and H5N8 subtypes have been reported across the country.

These outbreaks create several challenges for the poultry industry.

  • Mass bird culling: Authorities may need to destroy infected and exposed poultry to prevent further transmission.
  • Financial losses: Farmers can lose entire flocks, resulting in significant income disruption.
  • Supply chain disruptions: Restrictions on poultry transportation can affect chicken and egg distribution.
  • Higher operating costs: Farmers face additional expenses related to disease monitoring, sanitation and farm biosecurity.
  • Trade restrictions: Outbreaks can affect domestic and international poultry trade.

The 2006 bird flu outbreak alone resulted in estimated direct and indirect economic losses of Rs 2,200 crore to Rs 3,000 crore.

According to government estimates, a major outbreak could reduce India’s GDP growth by as much as 1.5% and put more than 20% of the country’s poultry population at risk if the disease spreads without effective control.

Recent Bird Flu Outbreaks Highlight the Threat

The vaccine’s unveiling comes amid renewed concerns about avian influenza outbreaks in different parts of India.

Tamil Nadu and Andhra Pradesh have reported recent H5N1 detections in poultry populations.

In Tamil Nadu’s Cuddalore district, bird flu infections resulted in thousands of bird deaths and subsequent containment measures, including culling and poultry movement restrictions.

Andhra Pradesh has also reported outbreaks, prompting authorities to establish infected and surveillance zones.

These developments demonstrate the continuing challenges associated with controlling highly pathogenic avian influenza.

For poultry farmers, an outbreak can result in the loss of months of investment. A vaccine that provides effective protection could eventually help reduce the frequency and severity of such disruptions.

However, vaccination will need to operate alongside disease surveillance, early testing, farm sanitation and other established containment measures.

What the Vaccine Means for India’s Poultry Industry

India has one of the world’s largest poultry industries, supporting millions of farmers, businesses and rural households.

The sector plays an important role in supplying affordable protein through chicken meat and eggs.

Recurring bird flu outbreaks create uncertainty for farmers and poultry businesses because containment measures can disrupt production and distribution.

The indigenous H5N1 vaccine could provide several potential benefits.

1. Protection for poultry populations

Effective vaccination could help protect susceptible chickens against the targeted H5N1 strain and reduce the impact of outbreaks.

2. Reduced financial losses

Preventing severe infections could reduce bird mortality and help farmers avoid some of the financial damage associated with disease outbreaks.

3. Improved domestic research capabilities

The development demonstrates India’s growing capabilities in veterinary biotechnology and domestic animal disease research.

4. Better disease management

The vaccine could become an additional tool for authorities managing avian influenza, alongside testing, surveillance and biosecurity measures.

5. Greater poultry sector stability

If successfully deployed at scale, vaccination could help reduce production disruptions and improve confidence across poultry supply chains.

These benefits will depend on real-world vaccine performance, manufacturing capacity and the government’s eventual vaccination policy.

Does the H5N1 Vaccine Protect Humans?

An important distinction is that the newly developed vaccine is intended for chickens, not humans.

H5N1 primarily affects birds but can occasionally infect humans, particularly those who have direct or indirect exposure to infected animals or contaminated environments.

According to figures cited by the Ministry of Agriculture from the World Health Organization, 1,003 human H5N1 infections, including 479 deaths, were reported across 25 countries, including India, since 2003.

Vaccinating poultry could potentially reduce human exposure by helping control infections among birds. However, it does not directly provide immunity to people or eliminate the possibility of human infections.

The development therefore represents an animal-health intervention with potential public-health benefits.

People should continue avoiding direct contact with sick or dead birds, while poultry workers should follow appropriate protective and hygiene practices.

Properly handled and thoroughly cooked chicken and eggs remain important food-safety practices.

What Happens Next?

Although the vaccine has been unveiled, several practical questions remain unanswered.

These include the commercial production arrangements, cost per dose, availability for poultry farmers and the number of birds that can be vaccinated.

The government will also need to clarify how vaccination will fit into India’s existing bird flu prevention and containment framework.

The availability of vaccine technology does not automatically mean that routine vaccination will immediately begin across all poultry farms.

The Bigger Picture

India’s first indigenous H5N1 vaccine represents an important milestone in domestic veterinary research. For years, bird flu outbreaks have exposed the vulnerability of the poultry industry, with farmers bearing significant financial losses whenever large-scale culling becomes necessary. Developing a vaccine against the H5N1 strain circulating in India could provide an additional layer of protection while strengthening the country’s animal disease preparedness.

The development also highlights the economic importance of investing in domestic biotechnology. As India expands its agricultural and food production capabilities, controlling infectious animal diseases will become increasingly important. A successful vaccination programme could support poultry farmers, improve supply chain stability and reduce the economic consequences of future outbreaks.

Looking Ahead

The immediate focus will be on commercial manufacturing, distribution planning and establishing the vaccination protocols required for poultry farms. The government and ICAR-NIHSAD will need to provide further details about pricing, production capacity and the conditions under which farmers can access the vaccine.

If the vaccine delivers effective protection under commercial farming conditions, it could become an important addition to India’s bird flu prevention strategy. Its long-term impact will depend on widespread implementation where appropriate, continued disease surveillance and coordination between veterinary authorities, research institutions and poultry businesses.


SEO Metadata

SEO Title: India Unveils First Indigenous H5N1 Vaccine to Protect Chickens From Bird Flu

Meta Description: India launches its first indigenous H5N1 bird flu vaccine, developed by ICAR-NIHSAD, to protect chickens and strengthen poultry disease control.

Suggested URL Slug: india-first-indigenous-h5n1-bird-flu-vaccine

Focus Keyword: India’s H5N1 vaccine

Secondary Keywords: Indigenous bird flu vaccine, H5N1 vaccine for chickens, ICAR-NIHSAD, bird flu in India, poultry industry India, avian influenza vaccine

Get the day’s top stories in your inbox

One concise email. No spam, unsubscribe anytime.